Aktsia Filana Therapeutics Inc (FLNA) hind ja uudised

Sümbolid Sümbolid	Hind	Muutus	% muutus	Trend	Eelm. sulgemishind	Ava	Kõrge	Madal	Maht	Turu kapit.
SIXB Materials SIXB Materials	SIXB +0,25%	1 104,10	+2,73	+0,25%	—	1 101,37	1 103,63	1 105,31	1 091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1 197,81	−1,02	−0,09%	—	1 198,83	1 199,68	1 199,75	1 182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 740,41	−15,54	−0,88%	—	1 755,95	1 754,06	1 756,03	1 734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3 228,71	+89,80	+2,86%	—	3 138,91	3 189,30	3 230,85	3 174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1 457,12	−20,31	−1,37%	—	1 477,43	1 474,12	1 474,12	1 451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2 399,84	+19,65	+0,83%	—	2 380,19	2 389,34	2 403,04	2 380,47	—	—

FLNA:BMV

Filana Therapeutics Inc

30,76 MX$

0,00%

(0,00) 1 p

7. apr, 12:31:31 GMT −6 · MXN

Kõik sümbolid

1 p

5 p

1 kuu

6 kuud

YTD

1 a

5 a

MAX

	Sümbol	Hind	Muutus	% muutus

Üksuse FLNA põhistatistika genereerimine…

Turu kapit.

77,76 mln

Keskm. maht

13,00

Maht

0,00

52 näd kõrgeim

56,00 MX$

52 näd madalaim

30,00 MX$

Töötajate arv

Seotud aktsiad

Axsome Therapeutics Inc

185,96 $

+1,77%

RLMD

Relmada Therapeutics Inc

Uudised

Erinevatest veebiallikatest

MarketBeat

32 minuti eest

Uniti Group Inc. (NASDAQ:UNIT) Given Consensus Recommendation of "Hold" by Brokerages

MarketBeat

32 minuti eest

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Moderate Buy" by Brokerages

Simply Wall Street

33 minuti eest

Could Broader Physician Interest In Brinsupri Subtly Shift Insmed’s (INSM) Long-Term Commercial Narrative?

Simply Wall Street

38 minuti eest

Is Sotera’s Regulatory Push and Reaffirmed 2024 Outlook Quietly Reshaping the SHC Investment Narrative?

Profiil

Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia

Teave üksuse Filana Therapeutics Inc kohta

Tegevjuht-

Töötajad19

Asutatud1998

PeakontoridAustin, Texas, Ameerika Ühendriigid

Sektor-

Veebisait-

Kõik väärtused on valuutas USD	märts 2025	juuni 2025	sept 2025	dets 2025
Tulu	-	-	-	-
Omahind	13,67 mln	5,12 mln	3,96 mln	3,85 mln
Kogukulu	13,67 mln	5,12 mln	3,96 mln	3,85 mln
Teadus- ja arenduskulud	-	-	-	-
Kõik teadus- ja arenduskulud	-	-	-	-
Müügi-, üld- ja halduskulud	7,92 mln	8,98 mln	7,90 mln	5,70 mln
Tegevuskulu	7,92 mln	8,98 mln	7,90 mln	5,70 mln
Kõik tegevuskulud	21,59 mln	14,09 mln	11,86 mln	9,55 mln
Tegevustulu	−21,59 mln	−14,09 mln	−11,86 mln	−9,55 mln
Muu tegevusväline tulu	−82,00 tuh	−46,00 tuh	−114,00 tuh	39,00 tuh
EBT, sh ebatavalised üksused	−23,40 mln	−44,22 mln	−10,81 mln	−12,54 mln
EBT, v.a ebatavalised üksused	−20,40 mln	−12,92 mln	−10,81 mln	−8,54 mln
Tulumaksukulu	-	-	-	-
Kehtiv maksumäär	-	-	-	-
Muud tegevuskulud	-	-	-	-
Netosissetulek	−23,40 mln	−44,22 mln	−10,81 mln	−12,54 mln
Puhaskasumi marginaal	-	-	-	-
Aktsiatulu	-	-	-	-
Intressi- ja investeerimistulu	1,26 mln	1,21 mln	1,17 mln	974,00 tuh
Intressikulu	-	-	-	-
Netointressikulud	1,26 mln	1,21 mln	1,17 mln	974,00 tuh
Kulum ja amortisatsiooni kulud	-	-	-	-
EBITDA	−21,37 mln	−13,87 mln	−11,73 mln	−9,18 mln
Kasum või kahjum varade müügist	-	-	-	-

AI genereeritud sisu võib sisaldada vigu. Lisateave

AbiSaada tagasisidetPrivaatsus Tingimused Lahtiütlus

Finance

Uuring